Valuation: Yuhan Corporation

Market Cap 5,892B 4.38B 3.93B 3.62B 3.29B 6.23B 411B 6.4B 43.38B 17.29B 220B 16.45B 16.1B 696B P/E 2026 *
43.8x
P/E 2027 * 28.8x
Enterprise Value 5.82B 4.33M 3.88M 3.58M 3.25M 6.15M 406M 6.32M 42.86M 17.08M 218M 16.26M 15.91M 688M EV / Sales 2026 *
2.47x
EV / Sales 2027 * 2.27x
Free-Float
59.15%
Yield 2026 *
0.73%
Yield 2027 * 0.73%
1 day+0.51%
1 week+2.60%
Current month+5.19%
1 month+8.07%
3 months-3.66%
6 months-8.78%
Current year-29.72%
1 week 77,100
Extreme 77100
83,800
1 month 69,000
Extreme 69000
89,800
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
129,200
3 years 57,142.86
Extreme 57142.857142
166,900
5 years 47,571.43
Extreme 47571.428571
166,900
10 years 24,550.49
Extreme 24550.486545
166,900
Manager TitleAgeSince
Chief Executive Officer 71 2021-03-18
Director of Finance/CFO 58 -
President 67 2024-03-14
Director TitleAgeSince
Chairman 75 2021-03-18
Director/Board Member 71 2015-03-19
Director/Board Member 62 2020-02-29
Date Insider Type Main position Quantity % Market Cap. Importance
6/30/25 Buy

Chairperson

200 0.0002%
6/25/25 Buy

Chief Executive Officer

720 0.0009%
6/24/25 Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+0.51%+2.60%-31.00%+33.79% 4.36B
-1.12%+0.35%+43.93%+132.24% 1,276B
-1.35%+0.50%+43.26%+88.10% 676B
-1.36%-1.38%+29.12%+109.72% 519B
-0.63%+1.16%+38.73%+67.75% 388B
-1.80%-3.02%+60.33%+42.31% 365B
-1.47%-1.10%+27.57%+56.91% 307B
-0.32%-1.10%+3.00%+35.34% 287B
-0.89%-3.34%+36.65%+73.41% 252B
-0.74%-2.48%+38.83%+127.09% 212B
Average -0.91%+1.67%+29.04%+76.67% 429B
Weighted average by Cap. -1.14%+2.50%+38.29%+93.36%

Financials

2026 *2027 *
Net sales 2,355B 1.75B 1.57B 1.45B 1.32B 2.49B 164B 2.56B 17.34B 6.91B 88.02B 6.58B 6.44B 278B 2,549B 1.9B 1.7B 1.57B 1.42B 2.69B 178B 2.77B 18.77B 7.48B 95.27B 7.12B 6.97B 301B
Net income 134B 99.43M 89.17M 82.18M 74.63M 141M 9.32B 145M 984M 392M 4.99B 373M 365M 15.79B 202B 150M 135M 124M 113M 214M 14.1B 220M 1.49B 593M 7.56B 564M 552M 23.88B
Net Debt -70.68B -52.59M -47.16M -43.46M -39.47M -74.7M -4.93B -76.79M -520M -207M -2.64B -197M -193M -8.35B -111B -82.4M -73.89M -68.1M -61.85M -117M -7.73B -120M -815M -325M -4.14B -309M -303M -13.08B
Projected Income Statement - Annual - Yuhan Corporation
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,082
Date Price Change Volume
26-11-10 ₩79,000.00 +0.51% 165,015
26-11-10 ₩78,600.00 +1.03% 119,575
26-11-09 ₩77,800.00 -3.23% 220,137
26-11-06 ₩80,400.00 -2.66% 276,160
26-11-05 ₩82,600.00 +5.63% 354,444
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Yuhan Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
78,600.00KRW
Average target price
112,058.82KRW
Spread / Average Target
+42.57%
  1. Stock Market
  2. Stocks
  3. A000100 Stock